glp 1 with diverticulitis Ozempic and Diverticulitis: Risks and Considerations Digestive Health and GLP-1 Medications:

In response, Novo Nordisk is advancing several next-generation candidates: Oral Wegovy is expected to receive FDA review by late 2025, potentially becoming the first oral GLP-1 approved for weight management

Unlike supplements, prescription peptides are produced by licensed compounding pharmacies and used under direct medical supervision

Patients must also not have type 2 diabetes, moderate-to-severe sleep apnea, or fatty liver disease because their Medicare plan may already cover GLP-1s

The Medicare GLP-1 Bridge is a temporary program that will run through December 2027

A recent analysis on GLP-1 use in New York City showed that theres a higher concentration of GLP-1 use for weight management in wealthy neighborhoods